Loading...
Keywords
Last Name
Institution

Connection

Bradley Warady to Recombinant Proteins

This is a "connection" page, showing publications Bradley Warady has written about Recombinant Proteins.

 
Connection Strength
 
 
 
0.592
 
  1. Mahan JD, Warady BA, Frane J, Rosenfeld RG, Swinford RD, Lippe B, Davis DA. First-year response to rhGH therapy in children with CKD: a National Cooperative Growth Study Report. Pediatr Nephrol. 2010 Jun; 25(6):1125-30.
    View in: PubMed
    Score: 0.088
  2. Seikaly MG, Waber P, Warady BA, Stablein D. The effect of rhGH on height velocity and BMI in children with CKD: a report of the NAPRTCS registry. Pediatr Nephrol. 2009 Sep; 24(9):1711-7.
    View in: PubMed
    Score: 0.083
  3. Warady BA, Zobrist RH, Wu J, Finan E. Sodium ferric gluconate complex therapy in anemic children on hemodialysis. Pediatr Nephrol. 2005 Sep; 20(9):1320-7.
    View in: PubMed
    Score: 0.064
  4. Warady BA, Kausz A, Lerner G, Brewer ED, Chadha V, Brugnara C, Dahl NV, Watkins SL. Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol. 2004 Jun; 19(6):655-61.
    View in: PubMed
    Score: 0.059
  5. Ng DK, Carroll MK, Kaskel FJ, Furth SL, Warady BA, Greenbaum LA. Patterns of recombinant growth hormone therapy use and growth responses among children with chronic kidney disease. Pediatr Nephrol. 2021 12; 36(12):3905-3913.
    View in: PubMed
    Score: 0.048
  6. Chanu P, Schaefer F, Warady BA, Schmitt CP, Reigner B, Schnetzler G, Meyer Reigner S, Eisner M, Weichert A, Frey N. Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. Br J Clin Pharmacol. 2020 04; 86(4):801-811.
    View in: PubMed
    Score: 0.044
  7. Warady B, Watkins SL. Current advances in the therapy of chronic renal failure and end stage renal disease. Semin Nephrol. 1998 May; 18(3):341-54.
    View in: PubMed
    Score: 0.039
  8. Schwartz ID, Warady BA. Cadaveric renal allograft rejection after treatment with recombinant human growth hormone. J Pediatr. 1992 Oct; 121(4):664-6.
    View in: PubMed
    Score: 0.026
  9. Warady BA, Sabath RJ, Smith CA, Alon U, Hellerstein S. Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis. Pediatr Nephrol. 1991 Nov; 5(6):718-23.
    View in: PubMed
    Score: 0.025
  10. Warady BA. Recombinant human erythropoietin: duplicate publication. Pediatr Nephrol. 1991 Nov; 5(6):763.
    View in: PubMed
    Score: 0.025
  11. Seikaly MG, Salhab N, Warady BA, Stablein D. Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS. Pediatr Nephrol. 2007 Aug; 22(8):1195-204.
    View in: PubMed
    Score: 0.018
  12. Mahan JD, Warady BA. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol. 2006 Jul; 21(7):917-30.
    View in: PubMed
    Score: 0.017
  13. Gorman G, Fivush B, Frankenfield D, Warady B, Watkins S, Brem A, Neu A. Short stature and growth hormone use in pediatric hemodialysis patients. Pediatr Nephrol. 2005 Dec; 20(12):1794-800.
    View in: PubMed
    Score: 0.016
  14. Neu AM, Fivush BA, Warady BA, Watkins SL, Friedman AL, Brem AS, Goldstein S, Frankenfield DL. Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients. Pediatr Nephrol. 2003 Nov; 18(11):1172-6.
    View in: PubMed
    Score: 0.014
  15. Schwartz ID, Warady BA, Reddig N, Meek K. Elevated glycosylated hemoglobin in a patient receiving recombinant erythropoietin. Pediatr Nephrol. 1996 Dec; 10(6):809-10.
    View in: PubMed
    Score: 0.009
  16. Alon US, Allen S, Rameriz Z, Warady BA, Kaplan RA, Harris DJ. Lidocaine for the alleviation of pain associated with subcutaneous erythropoietin injection. J Am Soc Nephrol. 1994 Oct; 5(4):1161-2.
    View in: PubMed
    Score: 0.008
  17. Kaplan RA, Allen S, Warady BA, Alon US. Effect of lidocaine on the hematopoietic properties of recombinant human erythropoietin in the uremic rat. Pediatr Nephrol. 1994 Aug; 8(4):477-9.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.